The TLR4-NF-κB signaling axis may represent a critical mechanistic link between Inflammatory bowel disease (IBD) and CRC, suggesting novel therapeutic and preventive strategies for IBD and CRC (Abdelazeem et al., 2021). This evidence concerns the gene NFKB1 and inflammatory bowel disease.